drugset / Trial / NCT03921099

Impact of Ascorbic Acid in the Prevention of Vancomycin Induced Nephrotoxicty

NCT03921099

Phase 4 Unknown 40 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelHealth-services research

Summary

A Randomized controlled trial aiming to investigate whether ascorbic acid has a role in preventing vancomycin induced nephrotoxicity or not in critically ill patients.

Timeline

Start
2019-01-17
Primary completion
2020-07
Completion
2020-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified 1 g Oral

Indications